World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21116
World Ranking
15293
National Ranking
585

Overview

Harry Hollema is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans medicine with a strong focus on biochemistry, genetics, and molecular biology, reflected by 13 publications in medicine and 11 in biochemistry, genetics, and molecular biology.

The main subfields of Hollema's work include genetics, oncology, immunology, cancer research, and pathology and forensic medicine. They have contributed notably to topics such as BRCA gene mutations in cancer, cancer immunotherapy and biomarkers, immunotherapy and immune responses, cancer genomics and diagnostics, interferon and immune responses, viral infections and vectors, and cancer-related molecular mechanisms research.

Recent papers authored or coauthored by Hollema include:

  • Association of homozygous variants of STING1 with outcome in human cervical cancer (2020), published in Cancer Science
  • Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study (2020), published in Lara D. Veeken
  • Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients (2021), published in OncoImmunology
  • High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors (2023), published in Journal of Clinical Oncology
  • Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome (2020), published in BMC Women s Health

Hollema frequently collaborates with several researchers, including:

  • Marian J.E. Mourits
  • Joost Bart
  • Geertruida H. de Bock
  • Iris A.S. Stroot
  • Marise M. Wagner

Their work is often published in venues such as E-Posters, Cancer Science, Lara D. Veeken, OncoImmunology, and the Journal of Clinical Oncology, with contributions distributed across these platforms.

Best Publications

  • Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

    Liesbeth Bergman;Maureen L R Beelen;Maarten P W Gallee;Harry Hollema

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

    Ninke Leffers;Marloes J. M. Gooden;Renske A. de Jong;Baukje-Nynke Hoogeboom

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

    Wouter B. Nagengast;Elisabeth G. de Vries;Geke A. Hospers;Nanno H. Mulder

  • Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

    Ying Wu;Maran J.W. Berends;Rob G.J. Mensink;Claudia Kempinga

  • Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline Variant

    Maran J.W. Berends;Ying Wu;Rolf H. Sijmons;Rob G.J. Mensink

  • Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins

    Boudewijn E. C. Plaat;Harry Hollema;Willemina M. Molenaar;Gerben H. Torn Broers

  • Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

    Marc Baay;Wim Quint;J. Koudstaal;H. Hollema

  • Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections

    Sibrand Poppema;Harry Hollema;Lydia Visser;Hans Vos

  • Vulvar carcinoma: The price of less radical surgery

    Joanne A De Hullu;Harry Hollema;Sietske Lolkema;Marike Boezen

  • Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study

    Maaike H Oonk;Bettien M van Hemel;Harry Hollema;Joanne A de Hullu

  • Tamoxifen treatment and gynecologic side effects: a review.

    Marian J.E Mourits;Elisabeth G.E De Vries;Pax H.B Willemse;Klaske A Ten Hoor

  • Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

    Gerben Duns;Eva van den Berg;Inge van Duivenbode;Jan Osinga

  • Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.

    Liqiang Qi;Joost Bart;Lu Ping Tan;Inge Platteel

  • Tissue distribution of the death ligand TRAIL and its receptors

    Diana C. Spierings;Elisabeth G. de Vries;Edo Vellenga;Fiona A. van den Heuvel

  • Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages

    Alida H. Klimp;Harry Hollema;Claudia Kempinga;Ate G. J. van der Zee

  • Lymphvascular space involvement : an independent prognostic factor in endometrial cancer

    Justine M. Briët;Harry Hollema;Nathalie Reesink;Jan G. Aalders

  • Management of extracolonic tumours in patients with Lynch syndrome

    Jan J Koornstra;Marian J E Mourits;Rolf H Sijmons;Annemarie M Leliveld

  • Risk and Prognosis of Endometrial Cancer After Tamoxifen for Breast Cancer

    L. R. Beelen;Maarten P. W. Gallee;Harry Hollema;Jantien Benraadt

Frequent Co-Authors

Hans W. Nijman
Hans W. Nijman University Medical Center Groningen
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen
Jan H. Kleibeuker
Jan H. Kleibeuker University Medical Center Groningen
Rolf H. Sijmons
Rolf H. Sijmons University of Groningen
Robert M.W. Hofstra
Robert M.W. Hofstra Erasmus University Rotterdam
Toos Daemen
Toos Daemen University Medical Center Groningen
Charles H.C.M. Buys
Charles H.C.M. Buys University of Groningen
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Wim Quint
Wim Quint Erasmus University Rotterdam
Ed Schuuring
Ed Schuuring University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want flexible options, a variety of online healthcare degrees can help you start or advance your career. For those just entering the nursing profession, an lpn accelerated program offers a fast track to becoming a licensed practical nurse, combining speed with accredited training.

Nurses looking to further specialize can explore bsn to np programs online. These programs provide advanced skills and qualifications, often allowing students to balance work and study.

If you’re drawn to the administrative side of healthcare, online healthcare administration programs are designed to develop the management expertise needed in clinics, hospitals, or large health organizations.

For professionals seeking graduate-level advancement without a large financial burden, the cheapest online mha degrees can offer a direct pathway to leadership roles in the industry.

These online pathways make it easier than ever to join or progress in the field of healthcare, regardless of your previous experience or current commitments.

Best Scientists Citing Harry Hollema

Trending Scientists

Recently Published Articles